Atlas Trials

Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer

Clinical trial NCT06261047 · COMPLETED

Trial details

NCT number
NCT06261047
Sponsor
Shandong Cancer Hospital and Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular CarcinomaRadiotherapy
Start date
2024-03-01
Primary completion
2026-01-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.